Taj Mahal Vision Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 3.08 M
as on 17-07-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2019
- Revenue -24.85%
(FY 2019)
- Profit 85.33%
(FY 2019)
- Ebitda 11.02%
(FY 2019)
- Net Worth -14.39%
(FY 2019)
- Total Assets 0.72%
(FY 2019)
About Taj Mahal Vision Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.08 M, as per Ministry of Corporate Affairs (MCA) records.
Gopal Agrawal and Mohamed Elmoghazi serve as directors at the Company.
- CIN/LLPIN
U24233MH2015PTC263943
- Company No.
263943
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2015
- Date of AGM
29 Jun 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Social Media
What products or services does Taj Mahal Vision Chemicals Private Limited offer?
Taj Mahal Vision Chemicals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Anti Infective Agent, Nutraceuticals & Dietary Supplements, Nutraceuticals, Pharma Ingredients & Raw Materials, API Intermediate, Anti Infective API, Personal Protective Equipment, PPE Kits, API Impurities.
Who are the key members and board of directors at Taj Mahal Vision Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Agrawal  | Director | 30-Apr-2015 | Current |
Mohamed Elmoghazi  | Director | 30-Apr-2015 | Current |
Financial Performance of Taj Mahal Vision Chemicals.
Taj Mahal Vision Chemicals Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 24.85% decrease. The company also saw a substantial improvement in profitability, with a 85.33% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Taj Mahal Vision Chemicals?
In 2019, Taj Mahal Vision Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Melia Pharmaceuticals Private LimitedActive 8 years 1 monthGopal Agrawal and Mohamed Elmoghazi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Taj Mahal Vision Chemicals?
Unlock and access historical data on people associated with Taj Mahal Vision Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Taj Mahal Vision Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Taj Mahal Vision Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
